Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China

Authors: Wei-Hua Jia, Qi-Hong Huang, Jian Liao, Weimin Ye, YY Shugart, Qing Liu, Li-Zhen Chen, Yan-Hua Li, Xiao Lin, Fa-Lin Wen, Hans-Olov Adami, Yi Zeng, Yi-Xin Zeng

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

Nasopharyngeal carcinoma (NPC) is a rare malignancy in most parts of the world but is common in southern China. A recent report from the Hong Kong Cancer Registry, a high-risk area for NPC in southern China, showed that incidence rate decreased by 29% for males and by 30% for females from 1980–1999, while mortality rate decreased by 43% for males and 50% for females. Changing environmental risk factors and improvements in diagnosis and treatment were speculated to be the major factors contributing to the downward trend of the incidence and mortality rates of NPC. To investigate the secular trends in different Cantonese populations with different socio-economic backgrounds and lifestyles, we report the incidences and mortality rates from two population-based cancer registries in Sihui and Cangwu counties from 1978–2002.

Methods

Incidence and mortality rates were aggregated by 5-year age groups and 5 calendar years. To adjust for the effect of difference in age composition for different periods, the total and age-specific rates of NPC incidence and mortality rate were adjusted by direct standardization according to the World Standard Population (1960). The Estimated Annual Percentage Change (EAPC) was used as an estimate of the trend.

Results

The incidence rate of NPC has remained stable during the recent two decades in Sihui and in females in Cangwu, with a slight increase observed in males in Cangwu from 17.81 to 19.76 per 100,000. The incidence rate in Sihui is 1.4–2.0 times higher during the corresponding years than in Cangwu, even though the residents of both areas are of Cantonese ethnicity. A progressive decline in mortality rate was observed in females only in Sihui, with an average reduction of 6.3% (p = 0.016) per five-year period.

Conclusion

To summarize, there is great potential to work in the area of NPC prevention and treatment in southern China to decrease NPC risk and improve survival risk rates in order to reduce M:I ratios. Future efforts on effective prevention, early detection and treatment strategies were also discussed in this paper. Furthermore, the data quality and completeness also need to be improved.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Muir CS: Cancer incidence in five continents. 1997, Lyon, IARC Sci Publ, 7: Electronic publication Parkin DM, Muir CS: Cancer incidence in five continents. 1997, Lyon, IARC Sci Publ, 7: Electronic publication
2.
go back to reference Jeannel D, Bouvier G, Huber A: Nasopharyngeal carcinoma, an epidemiological approach to carcinogenesis. Cancer Surv. 1999, 33: 125-155. Jeannel D, Bouvier G, Huber A: Nasopharyngeal carcinoma, an epidemiological approach to carcinogenesis. Cancer Surv. 1999, 33: 125-155.
3.
go back to reference Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH, Ko WM: Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980–99): an encouraging reduction in both incidence and mortality. Int J Cancer. 2003, 20: 680-685. 10.1002/ijc.10894.CrossRef Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH, Ko WM: Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980–99): an encouraging reduction in both incidence and mortality. Int J Cancer. 2003, 20: 680-685. 10.1002/ijc.10894.CrossRef
4.
go back to reference Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Gao YT: Cancer incidence trends in urban shanghai, 1972–1994: an update. Int J Cancer. 1999, 83: 435-440. 10.1002/(SICI)1097-0215(19991112)83:4<435::AID-IJC1>3.0.CO;2-J.CrossRefPubMed Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Gao YT: Cancer incidence trends in urban shanghai, 1972–1994: an update. Int J Cancer. 1999, 83: 435-440. 10.1002/(SICI)1097-0215(19991112)83:4<435::AID-IJC1>3.0.CO;2-J.CrossRefPubMed
5.
go back to reference Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS: Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992–2002. Am J Epidemiol. 2005, 162: 1174-1178. 10.1093/aje/kwi345.CrossRefPubMed Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS: Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992–2002. Am J Epidemiol. 2005, 162: 1174-1178. 10.1093/aje/kwi345.CrossRefPubMed
6.
go back to reference Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K: Trends in. Cancer Incidence in Singapore 1968–2002. Report No. 6. 2004, Singapore Cancer. Registry Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K: Trends in. Cancer Incidence in Singapore 1968–2002. Report No. 6. 2004, Singapore Cancer. Registry
7.
go back to reference Yang L, Parkin DM, Li L, Chen Y: Time trends in cancer mortality in China: 1987–1999. Int J Cancer. 2003, 106: 771-783. 10.1002/ijc.11300.CrossRefPubMed Yang L, Parkin DM, Li L, Chen Y: Time trends in cancer mortality in China: 1987–1999. Int J Cancer. 2003, 106: 771-783. 10.1002/ijc.11300.CrossRefPubMed
8.
go back to reference Waterhouse J, Muir C, Correa P, Powell J: Cancer Incidence in Five Continents. 1976, Lyon, IARC Sci Publ, 456- Waterhouse J, Muir C, Correa P, Powell J: Cancer Incidence in Five Continents. 1976, Lyon, IARC Sci Publ, 456-
9.
go back to reference Kleinbaum DG, Kupper LL, Muller KE: Applied regression analysis and other multivariable methods. 1988, Boston, PWSKENT Publishing Company Kleinbaum DG, Kupper LL, Muller KE: Applied regression analysis and other multivariable methods. 1988, Boston, PWSKENT Publishing Company
10.
go back to reference Lin TM, Chen KP, Lin CC, Hsu MM, Tu SM, Chiang TC, Jung PF, Hirayama T: Retrospective study on nasopharyngeal carcinoma. J Natl Cancer Inst. 1973, 51: 1403-1408.PubMed Lin TM, Chen KP, Lin CC, Hsu MM, Tu SM, Chiang TC, Jung PF, Hirayama T: Retrospective study on nasopharyngeal carcinoma. J Natl Cancer Inst. 1973, 51: 1403-1408.PubMed
11.
go back to reference De-The G, Dubouch P, Fontaine C, Wedderburn N, Carter RL, Edwards MB, Cohen B: Natural antibodies to EBV-VCA antigens in common marmosets (Callithrix jacchus) and response after EBV inoculation. Intervirology. 1980, 14: 284-291.CrossRefPubMed De-The G, Dubouch P, Fontaine C, Wedderburn N, Carter RL, Edwards MB, Cohen B: Natural antibodies to EBV-VCA antigens in common marmosets (Callithrix jacchus) and response after EBV inoculation. Intervirology. 1980, 14: 284-291.CrossRefPubMed
12.
go back to reference Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee HH, Kuo SL, Yang CS: Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol. 1985, 17: 47-49.CrossRefPubMed Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee HH, Kuo SL, Yang CS: Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol. 1985, 17: 47-49.CrossRefPubMed
13.
go back to reference Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J: Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes Control. 1991, 2: 125-131. 10.1007/BF00053132.CrossRefPubMed Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J: Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes Control. 1991, 2: 125-131. 10.1007/BF00053132.CrossRefPubMed
14.
go back to reference Ho JH, Huang DP, Fong YY: Salted fish and nasopharyngeal carcinoma in southern Chinese. Lancet. 1978, 2: 626-10.1016/S0140-6736(78)92844-1.CrossRefPubMed Ho JH, Huang DP, Fong YY: Salted fish and nasopharyngeal carcinoma in southern Chinese. Lancet. 1978, 2: 626-10.1016/S0140-6736(78)92844-1.CrossRefPubMed
15.
go back to reference Yu MC, Huang TB, Henderson BE: Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer. 1989, 43: 1077-1082.CrossRefPubMed Yu MC, Huang TB, Henderson BE: Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer. 1989, 43: 1077-1082.CrossRefPubMed
16.
go back to reference Yu MC, Mo CC, Chong WX, Yeh FS, Henderson BE: Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res. 1988, 48: 1954-1959.PubMed Yu MC, Mo CC, Chong WX, Yeh FS, Henderson BE: Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res. 1988, 48: 1954-1959.PubMed
17.
go back to reference Ning JP, Yu MC, Wang QS, Henderson BE: Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst. 1990, 82: 291-296.CrossRefPubMed Ning JP, Yu MC, Wang QS, Henderson BE: Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst. 1990, 82: 291-296.CrossRefPubMed
18.
go back to reference Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V: Environmental risk factors for nasopharyngeal carcinoma: a case-control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev. 1992, 1: 345-348.PubMed Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V: Environmental risk factors for nasopharyngeal carcinoma: a case-control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev. 1992, 1: 345-348.PubMed
19.
go back to reference Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese. Int J Cancer. 1994, 59: 585-590.CrossRefPubMed Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese. Int J Cancer. 1994, 59: 585-590.CrossRefPubMed
20.
go back to reference Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S: Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer. 1998, 77: 228-235. 10.1002/(SICI)1097-0215(19980717)77:2<228::AID-IJC11>3.0.CO;2-7.CrossRefPubMed Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S: Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer. 1998, 77: 228-235. 10.1002/(SICI)1097-0215(19980717)77:2<228::AID-IJC11>3.0.CO;2-7.CrossRefPubMed
21.
go back to reference IARC monograph: Tobacco smoking and tobacco smoke (Group 1). 1997, Lyon, IARC Sci Publ IARC monograph: Tobacco smoking and tobacco smoke (Group 1). 1997, Lyon, IARC Sci Publ
22.
go back to reference Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12: 421-429. 10.1016/S1044579X02000858.CrossRefPubMed Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12: 421-429. 10.1016/S1044579X02000858.CrossRefPubMed
23.
go back to reference Lee AH, Fraser ML, Meng X, Binns CW: Protective effects of green tea against prostate cancer. Expert Rev Anticancer Ther. 2006, 6: 507-513. 10.1586/14737140.6.4.507.CrossRefPubMed Lee AH, Fraser ML, Meng X, Binns CW: Protective effects of green tea against prostate cancer. Expert Rev Anticancer Ther. 2006, 6: 507-513. 10.1586/14737140.6.4.507.CrossRefPubMed
24.
go back to reference Cabrera C, Artacho R, Gimenez R: Beneficial effects of green tea--a review. J Am Coll Nutr. 2006, 79-99. Cabrera C, Artacho R, Gimenez R: Beneficial effects of green tea--a review. J Am Coll Nutr. 2006, 79-99.
25.
go back to reference Zeng YX, Jia WH: Familial nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12: 443-450. 10.1016/S1044579X02000871.CrossRefPubMed Zeng YX, Jia WH: Familial nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12: 443-450. 10.1016/S1044579X02000871.CrossRefPubMed
26.
go back to reference Jia WH, Collins A, Zeng YX, Feng BJ, Yu XJ, Huang LX, Feng QS, Huang P, Yao MH, Shugart YY: Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance. Eur J Hum Genet. 2005, 13: 248-252. 10.1038/sj.ejhg.5201305.CrossRefPubMed Jia WH, Collins A, Zeng YX, Feng BJ, Yu XJ, Huang LX, Feng QS, Huang P, Yao MH, Shugart YY: Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance. Eur J Hum Genet. 2005, 13: 248-252. 10.1038/sj.ejhg.5201305.CrossRefPubMed
27.
go back to reference Jia WH, Feng BJ, Xu ZL, Zhang XS, Huang P, Huang LX, Yu XJ, Feng QS, Yao MH, Shugart YY, Zeng YX: Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer. 2004, 101: 363-369. 10.1002/cncr.20372.CrossRefPubMed Jia WH, Feng BJ, Xu ZL, Zhang XS, Huang P, Huang LX, Yu XJ, Feng QS, Yao MH, Shugart YY, Zeng YX: Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer. 2004, 101: 363-369. 10.1002/cncr.20372.CrossRefPubMed
29.
go back to reference Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z, Zeng YX: Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet. 2002, 31: 395-399.PubMed Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z, Zeng YX: Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet. 2002, 31: 395-399.PubMed
31.
go back to reference Huang TB, Wang HM, Li JL: Screening program for nasopharyngeal carcinoma (NPC), early detection for NPC. Ai Zheng (Chinese). 1997, 16: 245-247. Huang TB, Wang HM, Li JL: Screening program for nasopharyngeal carcinoma (NPC), early detection for NPC. Ai Zheng (Chinese). 1997, 16: 245-247.
32.
go back to reference Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL: Comparability and Quality Control in Cancer Registration. IARC Technical Report No. 19. 1994, Lyon, International Agency for Research on Cancer Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL: Comparability and Quality Control in Cancer Registration. IARC Technical Report No. 19. 1994, Lyon, International Agency for Research on Cancer
33.
go back to reference Yi-Qin Zhang, Bao-Qing Wei: Improvement on Nasopharyngeal carcinoma radiotherapy during 20 years. Chinese Journal of Radiation Oncology (Chinese). 1999, 8: 73-76. Yi-Qin Zhang, Bao-Qing Wei: Improvement on Nasopharyngeal carcinoma radiotherapy during 20 years. Chinese Journal of Radiation Oncology (Chinese). 1999, 8: 73-76.
Metadata
Title
Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China
Authors
Wei-Hua Jia
Qi-Hong Huang
Jian Liao
Weimin Ye
YY Shugart
Qing Liu
Li-Zhen Chen
Yan-Hua Li
Xiao Lin
Fa-Lin Wen
Hans-Olov Adami
Yi Zeng
Yi-Xin Zeng
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-178

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine